hepurposeofthisreportwastoupdatethe2006InternationalLeagueAgainstEpilepsy(ILAE)reportandidentifythelevelofevidenceforlong-termefficacyoreffectivenessforantiepilepticdrugs(AEDs)asinitialmonotherapyforpatientswithnewlydiagnosedoruntreatedepilepsy.AllapplicablearticlesfromJuly2005untilMarch2012wereidentified,evaluated,andcombinedwiththepreviousysis(Glauseretal.,2006)toprovideacomprehensiveupdate.
Thepriorysismethodologywasutilizedwiththreemodifications:(1)thedetectablenoninferiorityboundaryapproachwasdroppedandbothfailedsuperioritystudiesandprespecifiednoninferioritystudieswereyzedusinganoninferiorityapproach,(2)thedefinitionofanadequatecomparatorwasclarifiedandnowincludesanabsoluteminimumpointestimateforefficacy/effectiveness,and(3)therelationshiptablebetweenclinicaltrialratings,levelofevidence,andconclusionsnolongerincludesarecommendationcolumntoreinforcethatthisreviewofefficacy/evidenceforspecificseizuretypesdoesnotimplytreatmentrecommendations.
Thisevidencereviewcontainsoneclarification:ThecommissionhasdeterminedthatclassIsuperioritystudiescanbedesignedtodetectuptoa20?solute(ratherthanrelative)differenceinthepointestimateofefficacy/effectivenessbetweenstudytreatmentandcomparatorusinganintent-to-treatysis.SinceJuly,2005,threeclassIrandomizedcontrolledtrials(RCT)and11classIIIRCTshebeenpublished.Thecombinedysis(1940-2012)nowincludesatotalof64RCTs(7withclassIevidence,2withclassIIevidence)and11meta-yses.
Newefficacy/effectivenessfindingsincludethefollowing:levetiracetamandzonisamidehelevelAevidenceinswithpartialonsetseizuresandbothethosuximideandvalproicacidhelevelAevidenceinchildrenwithchildhoodabsenceepilepsy.
Therearenomajorchangesinthelevelofevidenceforanyothersubgroup.LevetiracetamandzonisamidejoincarbamazepineandphenytoinwithlevelAefficacy/effectivenessevidenceasinitialmonotherapyforswithpartialonsetseizures.AlthoughethosuximideandvalproicacidnowhelevelAefficacy/effectivenessevidenceasinitialmonotherapyforchildrenwithabsenceseizures,therecontinuestobeanalarminglackofwelldesigned,properlyconductedepilepsyRCTsforpatientswithgeneralizedseizures/epilepsiesandinchildreningeneral.
Thesefindingsreinforcetheneedformulticenter,multinationaleffortstodesign,conduct,andyzefutureclinicallyrelevantadequatelydesignedRCTs.Whenselectingapatient'sAED,allrelevantvariablesandnotjustefficacyandeffectivenessshouldbeconsidered.
查看信源地址
编辑:jiang- 2022-05-02JNNP:使用扩散成像预报颞叶癫痫手术结果
- 2022-04-25隐源性哮喘死亡率翻倍
- 2022-04-25癫痫病的致病主要是什么
- 2022-04-13Diabetes Obes Metab:恩格列净对肝脂肪变性和纤维化标志物的影响及其与心肾结局的关系
- 2022-04-12病例学习:伴皮层下囊肿的巨脑性脑白质病
- 2022-04-11抗癫痫药物预防新发癫痫:任重而道远
- 病例学习:伴皮层下囊肿的巨脑性脑白质病
- 抗癫痫药物预防新发癫痫:任重而道远
- 预测癫痫患者再入院风险
- 特发性癫痫大发作药物治疗的首选
- 癫痫发作对中风患者静脉溶栓的长期转移有效
- 英国竞争监管机构指控辉瑞癫痫药品价格过高
- 2013国际抗癫痫联合会抗癫痫药用指南
- FDA批准Aptiom用于治疗患者癫痫发作
- 睡觉时突然抽搐 新生儿睡觉抽搐怎么办?
- 不注意这些问题,吃多少药都没用!
- 河南:无偿献血者用血费用一站式减免
- 癫痫的病因是什么?
- 癫痫治疗障碍仍难以克服
- 三庚酸酯可治疗1型转运体缺陷综合征
- 控制癫痫患者再次抽搐,不包括可选药物?
- 2015第31届国际癫痫大会(IEC)
- 月经期间要注意 有些药物和食物不能食用
- Medpage Today:不同类型的抗癫痫药物更有利
- 【用药问答】癫痫发作和局限性发作的首选治疗是什么?
- 2015 神经系统疾病诊疗进展
- UCB的Vimpat癫痫新适应症在美国获批
- 2016AAN:神经专家发表了有前途的专业见解
- 黑芝麻的营养价值 吃黑芝麻的好处
- 癫痫患者如何克服忘记吃药的问题?
- 癫痫患者手术评估新型工具
- 第四届全国临床脑电图实践基础理论与实践操作培训班
- 有利于癫痫病治疗的日常习惯上
- 怎么样对原发性癫痫病进行病人
- 早期小儿癫痫病有什么呕吐
- 2017癫痫病的最新治疗分析方法是什么
- 怎样治疗法癫痫病最有效
- 女性高血压的症状是什么呢
- 去广州儿童医院|小儿癫痫的成因有哪些?
- 亚甲基四氢叶酸还原酶缺陷导致的家族连续性癫痫连续性脑病
- 癫痫病不时发作怎么办
- 最新放射治疗癫痫病方法有什么
- 怎样外科手术癫痫病外科手术方法
- 成都市治疗癫痫病需要多少钱
- 癫痫病肉什么可以控制
- 天气越来越冷 癫痫患者预防病痛有妙招